BioSpace News Archive

Business

Creyon Bio and Cajal Neuroscience Announce Partnership to Develop Oligonucleotide-Based Medicines for Neurodegenerative Diseases

Creyon Bio, Inc. (“Creyon”) and Cajal Neuroscience, (“Cajal”) today announced a partnership to develop novel OBMs for neurodegenerative diseases.

May 1, 2024
·
3 min read
Catalyst Pharmaceuticals to Participate at the BofA Securities Health Care Conference 2024

Catalyst Pharmaceuticals, Inc. today announced that Richard J. Daly, President and CEO of Catalyst, along with other members of Catalyst’s management team, will participate at the upcoming BofA Securities Health Care Conference.

May 1, 2024
·
3 min read
PharmaTher’s Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine

PharmaTher Holdings Ltd. announced today Sairiyo Therapeutics Inc. has completed its clinical and regulatory package to evaluate Sairiyo’s patented reformulated enteric coated version of orally bioavailable cepharanthine (“PD-001”) as a potential treatment for infectious diseases and oncology in a Phase1 clinical study in Australia.

May 1, 2024
·
5 min read
Genetown

Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings

Ardelyx, Inc. today announced that additional data supporting XPHOZAH ® (tenapanor) will be presented at the National Kidney Foundation (NKF) 2024 Spring Clinical Meetings, to be held May 14-18, 2024, in Long Beach, California.

May 1, 2024
·
4 min read
Biotech Bay

Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting

Annexon, Inc. today announced the Company will have two presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held May 5-9, 2024 in Seattle, Washington.

May 1, 2024
·
7 min read
Genetown

Boston Scientific Announces Upcoming Investor Conference Schedule

Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences in May.

May 1, 2024
·
1 min read
Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154

Lipocine Inc. today announced that dosing of subjects has been completed in the pivotal pharmacokinetic (PK) study designed to support a New Drug Application (NDA) for LPCN 1154.

May 1, 2024
·
6 min read
Deals

INOVIO Reports Inducement Grants Under Inducement Plan - May 1, 2024

INOVIO today announced that it has made equity grants to two newly hired employees under its 2022 Inducement Plan (the “Inducement Plan”).

May 1, 2024
·
1 min read
Genetown

Ora, Inc. to showcase latest technologies and research at ARVO 2024, convene groundbreaking ophthalmic symposium Dry Horizons

Ora, Inc. announced its participation as a major exhibitor in the Association for Research in Vision and Ophthalmology 2024 conference, and as host and convener of the Dry Horizons Symposium in partnership with Ophthalmology Innovation Source.

May 1, 2024
·
5 min read
Johnson & Johnson submits regulatory applications to European Medicines Agency for TREMFYA® (guselkumab) for treatment of patients with ulcerative colitis and Crohn’s disease

Janssen-Cilag International NV, a Johnson & Johnson company, today announced it has submitted applications to the European Medicines Agency to include the treatment of adult patients with moderately to severely active ulcerative colitis and moderately to severely active Crohn’s disease.

May 1, 2024
·
14 min read